Antitumour necrosis factor alpha (anti-TNFα) agents include infliximab, adalimumab, golimumab, AVX-470 and OPRX-106. Janus kinase (JAK) inhibitors: tofacitinib, filgotinib and upadacitinib.

[31] This may be a mechanism whereby antiphospholipid antibodies ... of dermal venules and veins and may contribute to tissue necrosis. Our patient was simultaneously treated with ...

A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell Biol. 116 , 545 ...

intraosseous extravascular mechanisms (Gaucher's disease, steroid therapy, and caisson disease); and intraosseous intravascular mechanisms (sickle cell disease, coagulopathies, vasculitis ...